Author:
Nakano Yasuhiro,Iwata Nahoko,Ogura-Ochi Kanako,Hasegawa Kosei,Hirasawa Akira,Otsuka Fumio
Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine,Physiology,Internal Medicine
Reference9 articles.
1. Mulatero P, Tizzani D, Viola A, Bertello C, Monticone S, Mengozzi G, et al. Prevalence and characteristics of familial hyperaldosteronism: the PATOGEN study (Primary Aldosteronism in TOrino-GENetic forms). Hypertension. 2011;58:797–803.
2. Yokota K, Ogura T, Kishida M, Suzuki J, Otsuka F, Mimura Y, et al. Japanese family with glucocorticoid-remediable aldosteronism diagnosed by long-polymerase chain reaction. Hypertens Res. 2001;24:589–94.
3. Kamimaki T, Satoh S, Anzou M, Muroya K, Sugaya N, Honma K, et al. A Japanese family with glucocorticoid remediable hyperaldosteronism resulting from a chimeric gene between CYP11B1 and CYP11B2. Jpn J Inherit Metab Dis. 1995;11:110.
4. Litchfield WR, Anderson BF, Weiss RJ, Lifton RP, Dluhy RG. Intracranial aneurysm and hemorrhagic stroke in glucocorticoid-remediable aldosteronism. Hypertension. 1998;31:445–50.
5. Halperin F, Dluhy RG. Glucocorticoid-remediable aldosteronism. Endocrinol Metab Clin North Am. 2011;40:333–41.